4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-24-046085
EVP, Chief Development Officer acquired 3,874 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Forbes William P EVP, Chief Development Officer | 2024-04-19 | Option exercise | +3,874 | 82,874 | D | ||
| Derivatives | |||||||
| Forbes William P EVP, Chief Development Officer | 2024-04-19 | Option exercise · Restricted Stock Units | −3,874 | 58,115 | D | ||
Loading xslF345X05/ownership.xml…